Seite 41↓

6  Literaturverzeichnis

ABRAHAM, I.; CHIN, K.V.; GOTTESMAN, M.M.; MAYO, J.K.; SAMPSON, K.E. 1990 Transfection of a mutant regulatory subunit gene of cAMP-dependent protein kinase causes increased drug sensitivity and decreased expression of P-glycoprotein. Experimental cell research 189 133-141

AMADA, S.; NAKANO, H.; TSUNEYOSHI, M. 1995 Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins. International journal of gynecological pathology 14 134-142

AMBUDKAR, S.V.; LELONG, I.H.; ZHANG, J.; CARDARELLI, C.O.; GOTTESMAN, M.M.; PASTAN, I. 1992 Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. Proceedings of the National Academy of Sciences of the United States of America 89 8472-8476

ANDREASEN, P.A.; GEORG, B.; LUND, L.R.; RICCIO, A.; STACEY, S.N. 1990 Plasminogen activator inhibitors: hormonally regulated serpins. Molecular Cell Endocrinology 68 1-19

ANDREASEN, P.A.; EGELUND, R.; PETERSEN, H.H. 2000 The plasminogen activation system in tumor growth, invasion and metastasis. Cellular and Molecular Life Sciences 57 25-40

ASAKUNO, K.; KOHNO, K.; UCHIUMI, T.; KUBO, T.; SATO, S.; ISONO, M.; KUWANO, M. 1994 Involvement of a DNA binding protein, MDR-NF1 YB-1, in human MDR 1 gene in expression by Actinomycin D. Biochemical and biophysical research communications 199 1428-1435

AZZARIA, M.; SCHURR, E.; GROS, P. 1989 Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance. Molecular cell biology 9 5289-5297

BARGOU, R.C.; JÜRCHOTT, K.; WAGENER, C.; BERGMANN, S.; METZNER, S.; BOMMERT, K.; MAPARA, M.Y.; WINZER, K.-J.; DIETEL, M.; DÖRKEN, B.; ROYER, H.-D. 1997 Nuclear localization and increased levels of transcription factor YB-1 inprimary human breast cancers are associated with intrinsic MDR1 gene expression. Nature Medicine 4 447-450

BAYARSAIHAN, D.; ENKHMANDAKH, B.; LUKENS, L.N. 1996 Y-box proteins interact with the S1 nuclease-sensitive site in the chicken alpha 2 (I) collagen gene promoter. Biochemistry Journal 319 203-207

BECK, T.; WEIKEL, W.; BRUMM, C.; WILKENS, C.; POLLOW, K.; KNAPSTEIN, P.G. 1994 Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC). Gynecological Oncology 53 220-227

BIENZ, M. 1986: A CCAAT box confers cell-type-specific regulation on the Xenopus hsp70 gene in oocytes. Cell 46 1037-1042

BOUVET, P.; WOLFFE, A.P. 1994 A role for trnascription and FRGY2 in masking maternal mRNA within Xenopus oocytes. Cell 77 931-941

BOUVET, P.; MATSUMOTO, K.; WOLFFE, A.P. 1995 Sequnece-specific RNA recognition by Xenopus Y-box proteins. An essential role for the cold shock domain. Journal of biological chemistry 270 28297-28303

BRADLEY, G.; LING, V. 1994 P-glycoprotein, multidrug resistance and tumor progression. Cancer Metastasis Rev 13 223-233

BRÜNNER, N.; PYKE, C.; HANSEN, C.H.; ROMER, J.; GRONDAHL-HANSEN, J.; DANO, K. 1994 Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): Regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer. Cancer Treatment and Research 71 299-309

CHIN, K.V.; CHAUHAN, S.S.; PASTAN, I.; GOTTESMAN, M.M. 1990 Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells. Cell growth and differentiation 1 361-365

CHIN, K.V.; TANAKA, S.; DARLINGTON, G.; PASTAN, I.; GOTTESMAN; M.M. 1990 Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. Journal of biological chemistry 265 221-226

CHIN, K.-V.; UEDA, K.; PASTAN, I.; GOTTESMAN, M.M. 1992 Modulation of activity of the promoter of the human MDR 1 gene by Ras and p53. Science 255 459-462

CLEAVINGER, P.J.; SHIN, B.A.; KANDALA, J.C.; NAMBIAR, A.; SWAMYNATHAN, S.K.; GUNTAKA, R.V. 1996 Cloning of Rous sarcoma virus enhancer factor genes. II. RSV-EF-II, abundantly expressed in fibroblasts and muscle tissue, binds to an octamer sequence, 5'-GTACCACC-3', in the noncoding strand of RSV enhancer. Virology 222 133-143

DELGADO, R.C.; LUBIAN LOPEZ, D.M. 2001 Prognosis of breast cancer detected in women receiving hormone replacement therapy. Maturitas 38 147-156

DE OLIVIERA, D.E.; SEURINCK, J.; INZE, O.; MONTAGU, M.; BOTTERMAN, J. 1990 Differential expression of five Arabidopsis genes encoding glycine-rich proteins. Plant. Cell . 2 427-436

DHALLA, A.K.; RIRIE, S.S.; SWAMYNATHAN, S.K.; WEBER, K.T.; GUNTAKA, R.V. 1998 Chk-Yb-1b, a Y-box binding protein activates transcription from rat alpha 1 (I) procollagen gene promoter. Biochemistry Journal 336 373-379

DIDIER, D.K.; SCHIFFENBAUER, J.; WOULFE, S.L.; ZACEIS, M.; SCHWARTZ, B.D. 1988 Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proceedings of the National Academy of Sciences of the United States of America 85 7322-7326

DORN, A.; DURAND, B.; MARFLING, C.; LE MEUR, M.; BENOIST, C.; MATHIS, D. 1987 The conserved MHC class II boxes –X and Y are transcriptional control elements and specifically bind nuclear proteins. Proceedings of the National Academy of Sciences of the United States of America 84 6249-6253

FIRULLI, A.B.; MAIBENCO, D.C.; KINNIBURGH, A.J. 1992 The identification of a tandem H-DNA structure in the c-myc nuclease sensitive promoter element. Biochemical and biophysical research communications 185 264-270

FOEKENS, J.A.; PETERS, H.A.; LOOK, M.P.; PORTENGEN, H.; SCHMITT, M.; KRAMER, M.D.; BRUNNER, N.; JANICKE, F.; MEIJER-van-GELDER, M.E.; HENZEN-LOGMANS, S.C.; van-PUTTEN, W.L.; KLIJN, J.G. 2000 The urokinase system os plasminogen activation and prognosis in 2780 breast cancer patients. Cancer Research 60 636-643

GOLDSMITH, M.E.; MADDEN, M.J.; MORROW, C.S.; COWAN, K.H. 1993 A Y-box consensus sequence is required for basal expression of the human multidrug resistance (MDR1) gene. Journal of biological chemistry 268 5856-5860

GOLDSTEIN, L.J.; GALSKI, H.; FOJO, A.; WILLINGHAM, M.; LAI, S.L.; GAZDAR, A.; PIRKER, R.; GREEN, A.; CRIST, W.; BRODEUR, G.M. 1989 Expression of a multidrug resistance gene in human cancers. Journal of the National Cancer Institute 81 116-124

GONG, S.J.; RHA, S.Y.; CHUNG, H.C.; YOO, N.C.; ROH, J.K.; YANG, W.I. LEE, K.S.; MIN, J.S.; KIM, B.S.; CHUNG, H.C. 2000 Tissue urokinase-type plasminogen activator receptor levels in breast cancer. International Journal of Molecular Medicine 6 301-305

GOTTESMAN, M.M.; PASTAN, I. 1988 Resistance to multiple chemotherapeutic agents in human cancer cells. Trends in pharmacological sciences 9 54-58

GOTTESMAN, M.M.; PASTAN, I. 1988 The multidrug transporter, a double-edged sword. Journal of biological chemistry 263 12163-12166

GOTTESMAN, M.M.; PASTAN, I. 1993 Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual review of biochemistry 62 385-427

GRANT, C.E.; DEELAY, R.G. 1993 Cloning and characterization of chicken YB-1: regulation of expression in the liver. Molecular cell biology 13 4186-4196

GRONDAHL-HANSEN, J.; LUND, L.R.; RALFKIAER, E.; OTTEVANGER, V.; DANO, K. 1988 Urokinase- and tissue-type plasminogen activators in keratocytes during wound reepithelialization in vivo. Journal of Investigative Dermatology 90 790-795

GRONDAHL-HANSEN, J.; HILSENBECK, S.G.; CHRISTENSEN, I.J.; CLARK, G.M.; OSBORNE, C.K.; BRÜNNER, N. 1997 Prognostic significance of PAI-1 and uPA in cytosolic extracts obtained from node-positive breast cancer patients. Breast Cancer Research and Treatment 43 153-163

HAMADA, S.; KAMADA, M.; FURUMOTO, H.; HIRAO, T.; AONO, T. 1994 Expression of glutathione S-transferase-pi in human ovarian cancer as an indicator of resistance to chemotherapy. Gynecological oncology 52 313-319

HARBECK, N.; DETTMAR, P.; THOMSSEN, C.; BERGER, U.; ULM, K.; KATES, R.; JÄNICKE, F.; HÖFLER, H.; GRAEFF, H.; SCHMITT, M. 1999a Riskgroup discrimination in node-negative breast cancer using invasion and proliferation markers: six-year median follow-up. British Journal of Camcer 80 419-426

HARBECK, N.; THOMSSEN, C.; BERGER, U.; ULM, K.; KATES, R.; HÖFLER, H.; JÄNICKE, F.; GRAEFF, H.; SCHMITT, M. 1999b Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for for primary breast cancer and following first relapse . Breast Cancer Research Treatment 54 147-157

HARBECK, N.; ALT, U.; BERGER, U.; KATES, R.; KRUGER, A.; THOMSSEN, C.; JANICKE, F.; GRAEFF, H.; SCHMITT, M. 2000 Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancer. International Journal of Biological Markers 15 79-83

HARRIS, A.L.; HOCHHAUSER, D. 1992 Mechanisms of multidrug resistance in cancer treatment. Acta Oncologica 31 205-213

HONKOOP, A.H.; VAN DIEST, P.J.; DE JONG, J.S.; LINN, S.C.; GIACCONE, G.; HOEKMAN, K.; WAGSTAFF, J.; PINEDO, H.M. 1998 Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer. British Journal of Cancer 77 621-626

ISE, T.; NAGATANI, G.; IMAMURA, T.; KATO, K.; TAKANO, H.; NOMOTO, M.; IZUMI, H.; OHMORI, H.; OKAMOTO, T.; OHGA, T.; UCHIUMI, T.; KUWANO, M.; KOHNO, K. 1999 Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. Cancer research 59 342-346

ITO, K.; TSUTSUMI, K.; KUZUMAKI, T.; GOMEZ, P.F.; OTSU, K.; ISHIKAWA, K. 1994 A novel growth-inducible gene that encodes a protein with a conserved cold-shock domain. Nucleic Acids Research 22 2036-2041

ITO, K.; FUJIMORI, M.; NAKATA, S.; HAMA, Y.; SHINGU, K.; KOBAYASHI, S.; TSUCHIYA, S.; KOHNO, K.; KUWANO, M.; AMANO, J. 1998 Clinical significance of the increased multidrug resistance-associated protein (MRP) gene expression in patients with primary breast cancer. Oncol-Res. 10 99-109

JANZ, M.; HARBECK, N.; DETTMAR, P.; BERGER, U.; SCHMIDT, A.; JÜRCHOTT, K.; SCHMITT, M.; ROYER, H.-D. 2002 Y-Box factor YB-1 predicts Drug Resistence and patient outcome in breast cancer independent of clinically relevant tumor biological factors HER2, uPA and PAI-1 . International Journal of Cancer 97 278-282

JÄNICKE, F.; PRECHTL, A.; THOMSSEN, C.; HARBECK, N.; MEISNER, C.; UNTCH, M.; SWEEP, C.G.J.F.; SELBMANN, H.-K.; GRAEFF, H.; SCHMITT, M. 2001 Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1. Journal of the National Cancer Institute 93 913-920

JÜRCHOTT, K .: Untersuchungen zur subzellulären Lokalisation und zu den Funktionen von YB-1, einem Y-Box-Protein in Säugerzellen. Dissertationsarbeit zur Erlangung des Dr.rer.nat.

KAMURA, T.; YAHATA, H.; AMADA, S.; OGAWA, S.; SONODA, T.; KOBAYASHI, H.; MITSUMOTO, M.; KOHNO, K.; KUWANO, M.; NAKANO, H. 1999 Is nuclear expression of Y box-binding protein-1 a new prognostic factor in Ovarian Serous Adenocarcinoma? Cancer 85 2450-2454

KASAHARA, K.; FUJIWARA, Y.; NISHIO, K.; OHMORI, T.; SUGIMOTO, Y.; KOMIYA, K. 1991 Metallothionein content correlates with the sensitivity of human small cell lung cancer lines to cisplatin. Cancer research 51 3237-3242

KASHANCHI, F.; DUVALL, J.F.; DITTMER, J.; MIRESKANDARI, A.; REID, R.L.; GITLIN, S.D.; BRADY, J.N. 1994 Involvement of transcription factor YB-1 in human T-cell lymphotropic virus type I basal gene expression. Journal of virology 68 561-565

KAYE, S.B. 1997 Multidrug Resistence in Breast Cancer – Is The Jury In Yet? Journal of the National Cancer Institute 89 902-903

KNOOP, A.; ANDREASEN, P.A.; ANDERSEN, J.A.; HANSEN, S.; LAENKHOLM, A.V.; SIMONSEN, A.C.; ANDERSEN, J.; OVERGAARD, J.; ROSE, C. 1998 Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer. British Journal of Cancer 77 932-940

KOHNO, K.; TANIMURA, H.; SATO, S.; NAKAYAMA, Y.; MAKINO, Y.; WADA, M.; FOJO, A.T.; KUWANO, M. 1994 Cellular control of human multidrug resistance 1 (mdr1) gene expression in absence and presence of gene amplification in human cancer cells. Journal of biological chemistry 269 20503-20508

KOIKE, K.; UCHIUMI, T.; OHGA, T.; TOH, S.; WADA, M.; KOHNO, K.; KUWANO, M. 1997 Nuclear localization of the Y-box binding protein by ultraviolet irradiation. FEBS-Letters 417 390-394

KOLLURI, R.; TORREY, T.A.; KINNIBURGH, A.J. 1992 A CT promoter element binding protein: definition of a double-strand and a novel single-strand DNA binding motif. Nucleic acids research 20 111-116

KONDO, K.; INOUYE, M. 1991 TIP1, a cold shock inducible gene of Saccharomyces cerevisiae. Journal of biological chemistry 266 17537-17544

KONDO, K.; INOUYE, M. 1992 Yeast NSR1 protein that has structural similarity to mammalian nucleolus is involved in pre-rRNA processing. Journal of biological chemistry 267 16252-16258

KONDO, K.; KOWALSKI, L.R.Z.; INOUYE, M. 1992 Cold induction of yeast NSR1 protein and its role in pre-rRNA processing. Journal of biological chemistry 267 16259-16265

LADOMERY, M.; SOMMERVILLE, J. 1994 Binding of Y-box proteins to RNA: involvement of different protein domains. Nucleic acids research 22 5582-5589

LADOMERY, M.; SOMMERVILLE, J. 1995 A role for Y-box proteins in cell proliferation. Bio Essays 17 9-11

LAIHO, M.; KESKI-OJA, J. 1989 Growth factors in the regulation of pericellular proteolysis: a review. Cancer Research 49 2533-2553

LANDSMAN, D. 1992 RNP-1, an RNA-binding motif is conserved in the DNA-binding cold shock domain. Nucleic acids research 20 2861-2864

LEHNERT, M. 1998 Chemotherapy resistance in breast cancer. Anticancer Research 18 2225-2226

LINN, S.C.; HONKOOP, A.H.; HOEKMAN, K.; VAN-DER-VALK, P.; PINEDO, H.M.; GIACCONE, G. 1996 p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer. British journal of cancer 74 63-68

LINN, S.C.; PINEDO, H.M.; VAN ARK-OTTE, J.; VAN-DER-VALK, P.; HOEKMAN, K.; HONKOOP, A.H.; VERMORKEN, J.B.; GIACCONE, G. 1997 Expression of drug resistance proteins in breast cancer, in relation to chemotherapy. International Journal of Cancer 71 787-795

LIPSON, K.E.; CHEN, S.T.; KONIECKI, J.; KU, D.-H.; BASERGA, R. 1989 S-phase specific regulation by deletion mutants of the human thymidine promoter. Proceedings of the National Academy of Sciences of the United States of America 86 6848-6852

MAC DONALD, G.H.; ITOH-LINDSTROM, Y.; TING, J.P. 1995 The transcriptional regulatory protein , YB-1, promotes single-stranded regions in the DRA promoter. Journal of biological chemistry 270 3527-3533

MAQUAT, M.E. 1991 Nuclear mRNA export. Current opinions in cell biology 3 1004-1012

MERTENS, P.R.; ALFONSO-JAUME, M.A.; STEINMANN, K.; LOVETT, D.H. 1998 A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription. Journal of Biological Chemistry 273 32957-32965

MERTENS, P.R.; ALFONSO-JAUME, M.A.; STEINMANN, K.; LOVETT, D.H. 1999 YB-1 regulation of the human and rat gelatinase A genes via similar enhancer elements. Journal of the American Society of Nephrology 10 2480-2487

MIGNATTI, P.; ROBBINS, E.; RIFKIN, D.B. 1986 Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47 487-498

MINICH, W.B.; OVCHINIKOV, L.P. 1992 Role of cytoplasmic mRNP proteins in translation. Biochemie (Paris) 74 477-483

MINICH, W.B.; MAIDEBURA, I.P.; OVCHINIKOV, L.P. 1993 Purification and characterization of the major 50 kDa repressor protein from cytoplasmic mRNP of rabbit reticulocytes. European journal of biochemistry 212 633-638

MURRAY, M.T.; SCHILLER, D.L.; FRANKE, W.W. 1992 Sequence analysis of cytoplasmic mRNA-binding proteins of Xenopus oocytes identifies a family of RNA-binding proteins. Proceedings of the National Academy of Sciences of the United States of America 89 11-15

NEWKIRK, K.; FENG, W.; JIANG, W.; TEJERO, R.; EMERSON, S.D.; INOUYE, M.; MONTELIONE, G.T. 1994 Solution NMR structure of the major cold shock protein (CspA) from Escherichia coli: identification of a binding epitope for DNA. Proceedings of the National Academy of Sciences of the United States of America 91 5114-5118

NOGAE, I.; KOHNO, K.; KIKUCHI, J.; KUWANO, M.; AKIYAMA, S.-I.; KIUE, A.; SUZUKI, K.; YOSHIDA, Y.; CORNWELL, M.M.; PASTAN, I. et al. 1989 Analysis of structural features of dihydropyridine analogs needed to reverse multidrug resistance and to inhibit photoaffininty labeling of P-glycoprotein . Biochemical pharmacology 38 519-527

NOOTER, K.; STOTER, G. 1996 Molecular mechanisms of multidrug resistance in cancer chemotherapy. Pathology, research and practice 192 768-780

OBOKATA, J.; OHME, M.; HAYASHIDA, N. 1991 Nucleotide sequence of a cDNA clone encoding a putative glycine-rich protein of 19.7 kDa in Nicotiana sylvestris. Plant. Mol. Biol. 17 953-955

OHGA, T.; KOIKE, K.; ONO, M.; MAKINO, Y.; ITAGAKI, Y.; TANIMOTO, M.; KUWANO, M.; KOHNO, K. (1996): Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer research 56, S. 4224-4228

OSSOWSKI, L.; BIEGEL, D.; REICH, E. 1979 Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue. Cell 16 929-940

OSSOWSKI, L.; REICH, E. 1983 Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35 611-619

OSSOWSKI, L. 1988 In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bond urokinase. Journal of Biology 107 2437-2445

PEARSON, B.E.; NASHEUER, H.-P.; WANG, T.S.F. 1991 Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum-stimulated cells. Molecular Cell Biology 11 2081-2095

PINEDO, H.M.; GIACCONE, G. 1995 P-glycoprotein-a marker of cancer-cell behaviour. New England Journal of Medicine 333 1417-1419

PINOL-ROMA, S.; DREYFUSS, G. 1992 Shutting of pre-mRNA binding proteins between nucleus and cytoplasm. Nature 355 730-732

PRECHTL, A.; HARBECK, N.; THOMSSEN, C.; MEISNER, C.; BRAUN, M.; UNTCH, M. et al. 2000 Tumor-biological factors uPA and PAI-1 as stratification criteria of a multicenter adjuvant chemotherapy trial in node-negative breast cancer. International Journal of Biological Markers 15 73-78

RAJ, G.V.; SAFAK, M.; MAC DONALD, G.H.; KHALILI, K. 1996 Transcriptional regulation of human polyomavirus JC: evidence for a functional interaction between RelA (p65) and the Y-box-binding protein, YB-1. Journal of virology 70 5944-5953

RANJAN, M.; TAFURI, S.R.; WOLFFE, A.P. 1993 Masking mRNA from translation in somatic cells. Genes & Development 7 1725-1736

RICHTER, J.D.; SMITH, L.D. 1984 Reversible inhibition of translation by Xenopus oocyte specific proteins. Nature 309 378-380

ROMER, J.; LUND, L.R.; ERIKSEN, J.; RALFKIAER, E.; ZEHEB, R.; GELEHRTER, T.D.; DANO, K.; KRISTENSEN, P. 1991 Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. Journal of Investigative Dermatology 97 803-811

ROSS, D.D.; YANG, W.; ABRUZZO, L.V.; DALTON, W.S.; SCHNEIDER, E.; LAGE, H.; DIETEL, M.; GREENBERGER, L.; COLE, S.P.; DOYLE, L.A. 1999 Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. Journal of the National Cancer Institute 91 429-433

SANFILIPPO, O.; RONCHI, E.; DE-MARCO, C.; DI-FRONZO, G.; SILVESTRINI, R. 1991 Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicine and vincristine. European Journal of Cancer 27 155-158

SAPPINO, A.P.; HUARTE, J.; BELIN, D.; VASSALLI, J.D. 1989 Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos. Journal of Cellular Biology 109 2471-2479

SARKADI, B.; PRICE, E.M.; BOUCHER, R.C.; GERMANN, U.A.; SCARBOROUGH, G.A. 1992 Expression of the multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. Journal of biological chemistry 267 4854-4858

SCHMITT, M.; THOMSSEN, C.; ULM, K.; SEIDERER, A.; HARBECK, N.; HÖFLER, H.; JÄNICKE, F.; GRAEFF, H. 1997 Time varying prognostic impact of tumor biological factors urokinase (uPA), PAI-1, and steroid hormone recepror status in primary breast cancer. British Journal of Cancer 76 306-311

SCHNEIDER, J.; RUBIO, M.P.; BARBAZAN, M.J.; RODRIGUEZ-ESCUDERO, F.J.; SEIZINGER, B.R.; CASTRESANA, J.S. 1994 P-glycoprotein, HER-2 / neu and mutant p53 expression in human gynecologic tumors. Journal of National Cancer Institute 86 850-855

SCHNUCHEL, A.; WILTSCHECK, R.; CZISCH, M.; HERRLER, M.; WILLIMSKY, G.; GRAUMANN, P.; MARAHIEL, M.A.; HOLAK, T.A. 1993 Structure in solution of the major cold-shock protein from Bacillus subtilis. Nature 364 169-171

SCHINDELIN, H.; MARAHIEL, M.A.; HEINEMANN, U. 1993 Universal nucleic acid-binding domain revealed by crystal structure of the B.subtilis major cold-shock protein. Nature 364 164-168

SCHINDELIN, H.; JIANG, W:; INOUYE, M.; HEINEMANN, U. 1994 Crystal structure of CspA, the major cold shock protein of Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 91 5119-5123

SERAFINO, A.; SINIBALDI-VALLEBONA, P.; GAUDIANO, G.; KOCH, T.H.; RASI, G.; GARACI, E.; RAVAGNAN, G. 1998 Cytoplasmatic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms. Anticancer-Research 18 1159-1166

SHIBAO, K.; TAKANO, H.; NAKAYAMA, Y.; OKAZAKI, K.; NAGATA, N.; IZUMI, H.; UCHIUMI, T.; KUWANO, M.; KOHNO, K.; ITO, H. 1999 Enhanced coexpression of YB-1 and DNA topoisomerase II genes in human colorectal carcinomas. International Journal of Cancer 83 732-737

SPITKOVSKII, D.D.; ROYER-POKORA, B.; DELIUS, H.; KISSELJOV, F.; JENKINS, N.A.; GILBERT, D.J.; COPELAND, N.G.; ROYER, H.-D. 1992 Tissue restricted expression and chromosomal localization of the YB-1 gene encoding a 42 kD nuclear CCAAT binding protein. Nucleic Acids Research 20 797-780

SPITKOVSKII, D.D.; ROYER, H.D.; MAZURENKO, N.N.; MIKHALEVA, I.I.; PRUDCHENKO, I.A:; KORBUKH, I.A. 1993 In vivo identification of YB-1 protein, interacting with the enhancer of human papillomavirus (HPV) type 18, using antibodies to a synthetic peptide. Molecular biology of Moskow 27 81-91

STRICKLAND, S.; RICHARDS, W.G. 1992 Invasion of the trophoblasts. Cell 71 355-357

SUKHAI, M.; PIQUETTE-MILLER, M. 2000 Regulation of the multidrug resistance genes by stress signals. Journal of Pharmacology and Pharmacological Sciences 3 268-280

TAFURI, S.R.; WOLFFE, A.P. 1990 Xenopus Y-box transcription factors: molecular cloning, functional analysis and developmental regulation. Proceedings of the National Academy of Sciences of the United States of America 87 9028-9032

TAFURI, S.R.; WOLFFE, A.P. 1992 DNA binding, multimerization and transcription stimulation by the Xenopus Y box proteins in vitro. New Biologist 4 349-359

TAFURI, S.R.; WOLFFE, A.P. 1993 Selectice recruitment of masked maternal mRNA from messenger ribonucleoprotein particles containing FRGY2 (mRNP4). Journal of biological chemistry 268 24255-24261

TALVENSAARI-MATTILA, A.; PAAKKO, P.; HOYHTYA, M.; BLANCO-SEQUEIROS, G.; TURPEENNIEMI-HUJANEN, T. 1998 Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma . Cancer 83 1153-1162

TING, J.P.; PAINTER, A.; ZELEZNIK-LE, N.J.; MAC DONALD, G.; MOORE, T.M.; BROWN, A.; SCHWARTZ, B.D. 1994 YB-1 DNA-binding protein represses interferon gamma activation of class II major histocompatibility complex genes. Journal of experimental medicine 179 1605-1611

TRAVALI, S.; KU, D.H.; RIZZO, M.G.; OTTAVIO, L.; BASERGA, R. 1989 Structure of the human gene for the proliferating cell nuclear antigen. Journal of Biological Chemistry 264 7466-7472

VAN NOCKER, S.; VIERSTRA, R.D. 1993 Two cDNAs from Arabidopsis thaliana encode putative RNA binding proteins containing glycine-rich domains. Plant. Mol. Biol . 21 695-699

VERELLE P.; MEISSONNIER, F.; FONCK, Y.; FEILLEL, V.; DIONET, C.; KWIATKOWSKI, F.; PLAGNE, R.; CHASSAGNE, J. 1991 Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. Journal of National Cancer Institute 83 111-116

WOLFFE, A.P.; TAFURI, S.; RANJAN, M.; FAMILARI, M. 1992 The Y-box factors: a family of nucleic acid binding proteins conserved from Escherichia coli to man. New Biologist 4 290-298

WOLFFE, A.P. 1994 Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins . Bio Essays 16 245-251

WOLFFE, A.P.; MERIC, F. 1996 Coupling transcription to translation: a novel site for the regulation of eukaryotic gene expression. International journal of biochemical cell biology 28 247-257

ZAMORA, J.M.; PEARCE, H.L.; BECK, W.T. 1988 Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Molecular pharmacology 33 454-462


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
18.02.2004